Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 26, 2021; 9(33): 10143-10150
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10143
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10143
Value of GRACE and SYNTAX scores for predicting the prognosis of patients with non-ST elevation acute coronary syndrome
Xiao-Feng Wang, Ming Zhao, Fei Liu, Guo-Rong Sun, Department of Cardiology, Cangzhou Central Hospital, Cangzhou 061000, Hebei Province, China
Author contributions: Wang XF, Zhao M, Fei Liu F, and Sun GR contributed to the manuscript writing, revising; All authors confirmed the revised version of the manuscript.
Institutional review board statement: The study was reviewed and approved by the Cangzhou Central Hospital Institutional Review Board.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: There is no conflict of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xiao-Feng Wang, MSc, Doctor, Department of Cardiology, Cangzhou Central Hospital, No. 16 West Xinhua Road, Yunhe District, Cangzhou 061000, Hebei Provin ce, China. dahuanhuan888@163.com
Received: July 6, 2021
Peer-review started: July 6, 2021
First decision: July 26, 2021
Revised: August 9, 2021
Accepted: August 17, 2021
Article in press: August 17, 2021
Published online: November 26, 2021
Processing time: 139 Days and 1.5 Hours
Peer-review started: July 6, 2021
First decision: July 26, 2021
Revised: August 9, 2021
Accepted: August 17, 2021
Article in press: August 17, 2021
Published online: November 26, 2021
Processing time: 139 Days and 1.5 Hours
Core Tip
Core Tip: Risk stratification with a specific risk score can provide an estimate of patient prognosis and optimize clinical strategies. This study discussed the capabilities of GRACE and SYNTAX score in predicting the incidence of different major adverse cardiovascular events (MACEs) in patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS). It showed that the incidence of MACE was lower in patients with low and high GRACE and SYNTAX scores who received agents than in patients who underwent stent placement or coronary artery bypass grafting. These data suggest that GRACE and SYNTAX scores have prognostic value in NSTE-ACS patients.